Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00379678 · ClinicalTrials.gov registry record
Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 28
- Enrollment target
NCT00379678 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 28 participants.
The verdict
NCT00379678 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
THe study seeks to determine if pimecrolimus has a positive effect on increasing antimicrobial peptide expression and reducing vaccinia virus growth in the skin explants from patients with atopic dermatitis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00379678
The ClinicalTrials.gov registry entry for NCT00379678 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00379678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00379678 about?
NCT00379678 is a clinical study titled "Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis". THe study seeks to determine if pimecrolimus has a positive effect on increasing antimicrobial peptide expression and reducing vaccinia virus growth in the skin explants from patients with atopic dermatitis.
What is the current status of trial NCT00379678?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2006-09. Estimated completion is 2007-03.
Who is sponsoring clinical trial NCT00379678?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.